Apple Hit With $634M Verdict Over Masimo Health Tech Patent

California Federal Jury Awards Masimo Corp. $634 Million in Patent Infringement Case Against Apple Inc.

By Editorial Team

A California federal jury recently ruled in favor of Masimo Corp., awarding the company over $634 million in damages from tech giant Apple Inc. The verdict came after an eight-day trial, where it was determined that certain Apple Watches infringed on one of Masimo's pulse oximetry patents. The patented technology in question includes a feature that alerts users about abnormal heart rates.

The lawsuit, filed by Masimo Corp., alleged that Apple's use of this technology in their smartwatches violated Masimo's patent rights. The jury's decision to award such a substantial amount in damages highlights the significance of intellectual property protection in the tech industry.

Both companies were represented by prominent law firms during the trial. Gibson Dunn, Haynes Boone, Knobbe Martens, Sullivan & Cromwell, and WilmerHale were among the legal teams involved in the case.

The ruling is expected to have implications not only on the financial aspect but also on the future development and implementation of health-related technologies in wearable devices. The case sheds light on the importance of respecting intellectual property rights and the potential consequences of patent infringement in the competitive tech market.

Apple Inc. and Masimo Corp. are key players in the tech industry, known for their innovative products and contributions to the health tech sector. The outcome of this legal battle underscores the need for companies to conduct thorough patent research and ensure compliance with existing patents to avoid costly litigation.